Clustering of Adverse Events of Post-Market Approved Drugs
暂无分享,去创建一个
[1] Hans-Peter Kriegel,et al. DBSCAN Revisited, Revisited , 2017, ACM Trans. Database Syst..
[2] Satya Prakash Saraswat,et al. Healthcare RFID In Germany: An Integrated Pharmaceutical Supply Chain Perspective , 2014 .
[3] Shailendra Kadre,et al. Introduction to Statistical Analysis , 2015 .
[4] Lisa M. Lee,et al. Strengthening Global Public Health Surveillance through Data and Benefit Sharing , 2018, Emerging Infectious Diseases.
[5] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[6] S. Halvorsen,et al. Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study , 2020, European heart journal. Cardiovascular pharmacotherapy.
[7] G. Anusha,et al. Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring , 2010, Journal of young pharmacists : JYP.
[8] Francisco Gilberto Fernandes Pereira,et al. Environmental variables and errors in the preparation and administration of medicines. , 2018, Revista brasileira de enfermagem.
[9] D A Kessler,et al. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. , 1993, General hospital psychiatry.
[10] J. Kang,et al. Nurse-perceived Patient Adverse Events and Nursing Practice Environment , 2014, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[11] Jure Leskovec,et al. Modeling polypharmacy side effects with graph convolutional networks , 2018, bioRxiv.
[12] Joon-Seok Kim,et al. Fine-Grained Diversification of Proximity Constrained Queries on Road Networks , 2019, SSTD.
[13] Nikos A. Vlassis,et al. The global k-means clustering algorithm , 2003, Pattern Recognit..
[14] Dale J. Hu,et al. Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature , 2015, Journal of Racial and Ethnic Health Disparities.
[15] Stephanie J. Reisinger,et al. Using Data Mining to Predict Safety Actions from FDA Adverse Event Reporting System Data , 2007 .
[16] Marc Boyer,et al. Use of data mining at the Food and Drug Administration , 2016, J. Am. Medical Informatics Assoc..
[17] E. Brown,et al. The Medical Dictionary for Regulatory Activities (MedDRA) , 1999, Drug safety.
[18] David A. Kessler. Introducing MEDWatch: A New Approach to Reporting Medication and Device Adverse Effects and Product Problems , 1993 .
[19] Michael I. Jordan,et al. Latent Dirichlet Allocation , 2001, J. Mach. Learn. Res..
[20] Matthias Reumann,et al. Use of big data for drug development and for public and personal health and care , 2017, Genetic Epidemiology.
[21] Sergio J. Rey,et al. PySAL: A Python Library of Spatial Analytical Methods , 2010 .
[22] S. Willems,et al. Social disparities in patient safety in primary care: a systematic review , 2018, International Journal for Equity in Health.
[23] Rui Zhang,et al. Mining Adverse Events of Dietary Supplements from Product Labels by Topic Modeling , 2018, MedInfo.
[24] David Kauchak,et al. Modeling word burstiness using the Dirichlet distribution , 2005, ICML.
[25] P. Noseworthy,et al. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation. , 2016, Chest.
[26] H. Edelsbrunner,et al. Efficient algorithms for agglomerative hierarchical clustering methods , 1984 .
[27] ChengXiang Zhai,et al. Automatic labeling of multinomial topic models , 2007, KDD '07.
[28] P. Moran. Notes on continuous stochastic phenomena. , 1950, Biometrika.
[29] Hongfei Yan,et al. Comparing Twitter and Traditional Media Using Topic Models , 2011, ECIR.
[30] S. Weingart,et al. Racial and Ethnic Disparities in Patient Safety , 2017, Journal of patient safety.